» Articles » PMID: 26164801

Biodegradation of Pharmaceuticals in Hospital Wastewater by Staged Moving Bed Biofilm Reactors (MBBR)

Overview
Journal Water Res
Date 2015 Jul 13
PMID 26164801
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Hospital wastewater represents a significant input of pharmaceuticals into municipal wastewater. As Moving Bed Biofilm Reactors (MBBRs) appear to remove organic micro-pollutants, hospital wastewater was treated with a pilot plant consisting of three MBBRs in series. The removal of pharmaceuticals was studied in two experiments: 1) A batch experiment where pharmaceuticals were spiked to each reactor and 2) a continuous flow experiment at native concentrations. DOC removal, nitrification as well as removal of pharmaceuticals (including X-ray contrast media, β-blockers, analgesics and antibiotics) occurred mainly in the first reactor. In the batch experiment most of the compounds followed a single first-order kinetics degradation function, giving degradation rate constants ranged from 5.77 × 10(-3) to 4.07 h(-1), from -5.53 × 10(-3) to 9.24 × 10(-1) h(-1) and from 1.83 × 10(-3) to 2.42 × 10(-1) h(-1) for first, second and third reactor respectively. Generally, the highest removal rate constants were found in the first reactor while the lowest were found in the third one. This order was inverted for most compounds, when the removal rate constants were normalized to biomass, indicating that the last tank had the most effective biofilms. In the batch experiment, 21 out of 26 compounds were assessed to be degraded with more than 20% within the MBBR train. In the continuous flow experiment the measured removal rates were lower than those estimated from the batch experiments.

Citing Articles

How resistant is anammox biofilm against antibiotics: A special insight into anammox response towards fluoroquinolones.

Mamun F, Kumar R, Anwuta K, Das S, Jaagura M, Herodes K Heliyon. 2025; 11(1):e41339.

PMID: 39811371 PMC: 11729660. DOI: 10.1016/j.heliyon.2024.e41339.


Dynamics of antimicrobial resistance and susceptibility profile in full-scale hospital wastewater treatment plants.

Esmaeili-Khoshmardan M, Dabiri H, Rafiee M, Eslami A, Yazdanbakhsh A, Amereh F Water Sci Technol. 2024; 90(1):103-123.

PMID: 39007309 DOI: 10.2166/wst.2024.201.


Total RNA analysis of the active microbiome on moving bed biofilm reactor carriers under incrementally increasing micropollutant concentrations.

Martin J, Tisler S, Scheel M, Svendsen S, Anwar M, Zervas A FEMS Microbiol Ecol. 2024; 100(9).

PMID: 38986504 PMC: 11385203. DOI: 10.1093/femsec/fiae098.


Global trends in the research and development of medical/pharmaceutical wastewater treatment over the half-century.

Wang L, Xu Y, Qin T, Wu M, Chen Z, Zhang Y Chemosphere. 2023; 331:138775.

PMID: 37100249 PMC: 10123381. DOI: 10.1016/j.chemosphere.2023.138775.


Biofilm-based technology for industrial wastewater treatment: current technology, applications and future perspectives.

Maurya A, Kumar R, Raj A World J Microbiol Biotechnol. 2023; 39(5):112.

PMID: 36907929 DOI: 10.1007/s11274-023-03567-7.